Concord Medical Services (NYSE:CCM) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Concord Medical Services (NYSE:CCMFree Report) in a research note issued to investors on Saturday morning. The firm issued a sell rating on the stock.

Concord Medical Services Stock Performance

Shares of NYSE CCM opened at $5.48 on Friday. Concord Medical Services has a 12-month low of $3.82 and a 12-month high of $26.70. The firm’s 50-day simple moving average is $6.83 and its 200 day simple moving average is $6.72. The company has a current ratio of 0.32, a quick ratio of 0.30 and a debt-to-equity ratio of 1.14.

About Concord Medical Services

(Get Free Report)

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.

Recommended Stories

Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.